The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect that can diminish quality of life following treatment. To prevent hearing damage during cancer treatment, a University of Oklahoma researcher created a novel drug delivery system that transports medications to the inner ear; her studies about the promising innovation are published in the Journal of Controlled Release and the Journal of Nanobiotechnology.

The White Coat Ceremony holds a special place in the hearts of aspiring clinicians. It marks the next phase of their medical education as they begin their first-year orientation. For many, it marks a moment when the dream of becoming a healthcare professional becomes real.

A University of Oklahoma researcher recently received a $1.3 million grant from the U.S. Department of Defense to test a newly created mobile app designed to address health disparities among Black men diagnosed with prostate cancer.

A researcher at the University of Oklahoma College of Pharmacy at OU Health Sciences is playing a key role in a preclinical trial that is testing a non-addictive drug to treat post-traumatic stress disorder and alcohol use disorder. Recent findings from the trial are promising: The drug reduces symptoms of post-traumatic stress disorder like anxiety and increased pain sensitivity, while also decreasing alcohol consumption.